Free Trial
→ The AI Stock to Keep an Eye on Before Election Day (See Why) (From Prosperity Research) (Ad)tc pixel Free PHR Stock Alerts

Phreesia (PHR) Financials

Phreesia logo
$10.85 +0.04 (+0.41%)
Closing price 03:59 PM Eastern
Extended Trading
$10.60 -0.25 (-2.34%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Phreesia

Annual Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -38 -45 -91 -27 -118 -176 -137 -59 2.31
Consolidated Net Income / (Loss)		 -18 -15 -20 -27 -118 -176 -137 -59 2.31
Net Income / (Loss) Continuing Operations		 -18 -15 -20 -27 -118 -176 -137 -59 2.31
Total Pre-Tax Income 		-18 -15 -22 -27 -118 -176 -135 -56 -8.94
Total Operating Income		 -15 -9.49 -15 -26 -117 -177 -136 -58 -6.61
Total Gross Profit		 50 63 80 96 132 172 295 354 409
Total Revenue		 80 100 125 149 213 281 356 420 481
Operating Revenue		 80 100 125 149 213 281 356 420 481
Total Cost of Revenue		 30 37 45 52 81 109 61 66 71
Operating Cost of Revenue		 30 37 45 52 81 109 61 66 71
Total Operating Expenses		 65 72 95 122 249 348 432 412 416
Selling, General & Admin Expense		 19 20 30 40 69 80 80 77 80
Marketing Expense		 25 26 32 43 106 151 147 121 100
Research & Development Expense		 11 14 19 23 52 91 112 117 121
Depreciation Expense		 6.83 7.55 8.75 9.77 15 18 18 14 13
Amortization Expense		 2.81 4.04 5.17 6.14 6.32 7.32 12 14 18
Other Operating Expenses / (Income)		 - - - - - - 63 69 83
Total Other Income / (Expense), net		 -3.64 -5.57 -6.78 -1.57 -1.16 0.89 1.14 2.29 -2.33
Interest Expense		 3.64 3.50 2.45 1.57 1.08 0.00 2.97 2.35 7.45
Interest & Investment Income		 - - - - - 1.06 4.07 2.68 2.17
Other Income / (Expense), net		 0.00 -2.07 -4.33 0.00 -0.08 -0.18 0.04 1.96 2.95
Income Tax Expense		 0.00 0.00 -1.78 0.05 0.18 0.48 1.54 2.72 -11
Basic Earnings per Share		 ($24.81) ($24.53) ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Weighted Average Basic Shares Outstanding		 1.54M 1.84M 20.30M 39.52M 49.89M 52.44M 54.56M 57.59M 59.74M
Diluted Earnings per Share		 ($24.81) ($24.53) ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Weighted Average Diluted Shares Outstanding		 1.54M 1.84M 20.30M 39.52M 49.89M 52.44M 54.56M 57.59M 61.49M
Weighted Average Basic & Diluted Shares Outstanding		 1.54M 1.84M 20.30M 39.52M 51.95M 53.36M 56.39M 58.77M 60.76M

Quarterly Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Consolidated Net Income / (Loss)		 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Net Income / (Loss) Continuing Operations		 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Total Pre-Tax Income 		-30 -19 -17 -14 -5.38 -3.18 -0.56 5.13 -10 4.72 3.24
Total Operating Income		 -30 -19 -17 -14 -7.61 -3.29 -1.51 3.74 -5.56 6.75 7.61
Total Gross Profit		 63 67 69 72 76 99 100 82 169 113 110
Total Revenue		 95 101 102 107 110 116 117 120 127 131 129
Operating Revenue		 95 101 102 107 110 116 117 120 127 131 129
Total Cost of Revenue		 32 34 33 35 34 17 17 38 -42 18 19
Operating Cost of Revenue		 32 34 33 35 34 17 17 38 -42 18 19
Total Operating Expenses		 93 87 87 86 84 103 101 79 175 107 103
Selling, General & Admin Expense		 19 19 19 20 18 16 19 17 27 18 17
Marketing Expense		 36 32 30 30 29 26 25 24 25 24 25
Research & Development Expense		 30 29 30 29 30 32 29 29 31 28 28
Depreciation Expense		 4.35 3.52 3.92 3.57 3.17 2.99 3.28 3.20 3.51 3.37 3.34
Amortization Expense		 3.90 3.15 3.38 3.52 3.65 3.89 4.13 4.28 6.18 6.58 6.66
Other Operating Expenses / (Income)		 - - - - - 21 20 - - 26 24
Total Other Income / (Expense), net		 -0.85 0.21 -0.04 -0.12 2.24 0.11 0.94 1.39 -4.77 -2.03 -4.37
Interest Expense		 - - - - - 0.44 0.39 - - 2.32 1.73
Interest & Investment Income		 0.18 0.24 0.05 0.03 0.02 0.21 1.00 0.38 1.42 0.30 0.25
Other Income / (Expense), net		 0.08 -0.03 -0.09 -0.14 2.22 0.34 0.34 1.01 1.27 -0.01 -2.89
Income Tax Expense		 0.22 0.51 0.75 0.44 1.01 0.74 -1.22 0.85 -12 1.76 1.32
Basic Earnings per Share		 ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Weighted Average Basic Shares Outstanding		 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 59.59M 60.01M 59.74M 60.94M 61.88M
Diluted Earnings per Share		 ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Weighted Average Diluted Shares Outstanding		 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 61.69M 61.56M 61.49M 62.04M 62.46M
Weighted Average Basic & Diluted Shares Outstanding		 56.39M 57.40M 57.77M 58.12M 58.77M 59.50M 59.91M 60.29M 60.76M 61.81M 62.07M

Annual Cash Flow Statements for Phreesia

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents		 8.18 -8.96 89 128 95 -137 -89 -3.30 -10
Net Cash From Operating Activities		 -11 -2.13 0.83 2.89 -75 -90 -32 32 79
Net Cash From Continuing Operating Activities		 -11 -2.13 0.83 2.89 -75 -90 -32 32 79
Net Income / (Loss) Continuing Operations		 -18 -15 -20 -27 -118 -176 -137 -59 2.31
Consolidated Net Income / (Loss)		 -18 -15 -20 -27 -118 -176 -137 -59 2.31
Depreciation Expense		 9.64 12 14 16 21 25 29 28 31
Amortization Expense		 2.29 2.44 2.42 2.41 2.50 2.01 1.38 2.05 3.55
Non-Cash Adjustments To Reconcile Net Income		 -0.37 1.59 11 16 38 62 75 67 65
Changes in Operating Assets and Liabilities, net		 -4.51 -2.69 -6.53 -4.16 -18 -3.43 -1.41 -6.28 -23
Net Cash From Investing Activities		 -12 -11 -12 -25 -65 -26 -40 -24 -162
Net Cash From Continuing Investing Activities		 -12 -11 -12 -25 -65 -26 -40 -24 -162
Purchase of Property, Plant & Equipment		 -12 -9.83 -12 -19 -31 -26 -25 -24 -24
Acquisitions		 0.00 -1.19 - -6.51 -34 0.00 -15 0.00 -153
Other Investing Activities, net		 - - - - - - 0.00 0.00 16
Net Cash From Financing Activities		 31 4.19 100 151 235 -21 -17 -11 73
Net Cash From Continuing Financing Activities		 31 4.19 100 151 235 -21 -17 -11 73
Repayment of Debt		 -24 -8.30 -39 -23 -1.16 -0.61 -2.68 -1.35 -34
Issuance of Debt		 22 15 30 - 0.00 0.00 1.69 0.00 110
Issuance of Common Equity		 0.00 0.00 131 175 248 3.32 3.21 2.92 2.37
Other Financing Activities, net		 0.15 -2.11 -0.09 -1.20 -12 -24 -19 -13 -5.37
Effect of Exchange Rate Changes		 - - - - - 0.00 0.00 -0.11 -0.18
Cash Interest Paid		 2.80 2.80 2.31 1.47 0.80 0.76 1.31 2.19 1.61
Cash Income Taxes Paid		 - 0.00 0.00 0.06 0.05 0.04 0.04 3.07 1.90

Quarterly Cash Flow Statements for Phreesia

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Change in Cash & Equivalents		 -16 -7.99 2.27 -0.06 2.48 6.65 7.40 8.11 -33 2.57 -1.76
Net Cash From Operating Activities		 -3.08 -0.72 11 5.79 16 15 15 15 34 24 18
Net Cash From Continuing Operating Activities		 -3.08 -0.72 11 5.79 16 15 15 15 34 24 18
Net Income / (Loss) Continuing Operations		 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Consolidated Net Income / (Loss)		 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Depreciation Expense		 8.25 6.67 7.30 7.09 6.82 6.88 7.41 7.48 9.69 9.95 10.00
Amortization Expense		 0.27 0.25 0.24 1.38 0.17 0.17 0.30 0.17 2.90 0.55 0.24
Non-Cash Adjustments To Reconcile Net Income		 20 17 17 18 16 18 17 16 14 17 8.01
Changes in Operating Assets and Liabilities, net		 -0.54 -5.28 4.98 -6.01 0.03 -6.16 -10 -13 5.71 -6.19 -1.84
Net Cash From Investing Activities		 -8.16 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67 -143 4.80 22
Net Cash From Continuing Investing Activities		 -8.16 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67 -143 4.80 22
Purchase of Property, Plant & Equipment		 -7.86 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67 -5.14 -7.55 -4.50
Other Investing Activities, net		 - - - - - 0.00 - - - 12 27
Net Cash From Financing Activities		 -4.61 -1.83 -1.38 -1.65 -6.63 -0.84 -2.15 -0.67 77 -26 -42
Net Cash From Continuing Financing Activities		 -4.61 -1.83 -1.38 -1.65 -6.63 -0.84 -2.15 -0.67 77 -26 -42
Repayment of Debt		 -2.11 -0.44 -0.30 -0.30 -0.31 -0.36 -0.33 -0.35 -33 -116 -41
Issuance of Common Equity		 0.43 0.91 0.69 0.84 0.48 0.77 0.58 0.63 0.40 0.52 0.24
Other Financing Activities, net		 -2.93 -2.30 -1.78 -2.19 -6.79 -1.25 -2.40 -0.95 -0.78 -2.64 -1.19
Effect of Exchange Rate Changes		 - -0.00 -0.01 -0.01 -0.09 0.03 -0.09 -0.03 -0.09 -0.06 0.03
Cash Interest Paid		 0.66 0.48 0.38 0.60 0.74 0.32 0.33 0.24 0.72 3.85 0.70
Cash Income Taxes Paid		 -0.01 1.59 0.42 0.55 0.51 0.55 0.76 0.33 0.25 1.18 2.88

Annual Balance Sheets for Phreesia

This table presents Phreesia's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets		 59 159 327 494 370 370 388 664
Total Current Assets		 33 132 272 386 262 196 203 280
Restricted Cash		 - - - - - - - 74
Accounts Receivable		 16 22 29 40 51 65 74 97
Prepaid Expenses		 3.81 5.16 7.25 11 11 14 16 18
Other Current Assets		 12 14 17 21 24 29 30 91
Plant, Property, & Equipment, net		 14 14 0.00 0.00 22 17 24 0.00
Total Noncurrent Assets		 12 13 54 108 86 158 161 384
Noncurrent Note & Lease Receivables		 - - - - - - - 53
Goodwill		 0.25 0.25 8.31 34 34 76 76 170
Intangible Assets		 9.25 9.93 13 30 47 78 81 134
Noncurrent Deferred & Refundable Income Taxes		 0.00 0.78 0.66 0.52 0.08 - 0.00 1.59
Other Noncurrent Operating Assets		 2.23 1.77 32 44 5.58 4.13 4.73 25
Total Liabilities & Shareholders' Equity		 59 159 327 494 370 370 388 664
Total Liabilities		 64 57 63 77 82 119 124 327
Total Current Liabilities		 28 35 55 68 79 110 114 183
Short-Term Debt		 1.97 2.32 4.86 5.82 5.17 6.06 8.04 7.97
Accounts Payable		 3.75 6.02 4.39 5.12 11 8.48 5.62 11
Accrued Expenses		 5.51 9.24 18 20 22 37 37 41
Current Deferred Revenue		 6.49 5.40 11 16 18 24 33 50
Other Current Liabilities		 10 12 17 21 24 34 30 73
Total Noncurrent Liabilities		 36 22 8.37 8.76 3.20 8.76 9.58 143
Long-Term Debt		 28 22 6.47 7.42 2.73 5.40 8.15 92
Noncurrent Deferred Revenue		 - - - 0.07 0.13 0.10 0.12 0.24
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - 0.00 0.27 0.48 4.50
Other Noncurrent Operating Liabilities		 5.50 0.00 1.90 1.28 0.35 2.99 0.83 46
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -211 102 263 417 288 251 265 337
Total Preferred & Common Equity		 -211 102 263 417 288 251 265 337
Preferred Stock		 - - - - 0.00 0.00 0.00 0.00
Total Common Equity		 -211 102 263 417 288 251 265 337
Common Stock		 0.02 387 580 861 927 1,040 1,112 1,182
Retained Earnings		 -211 -284 -312 -430 -606 -743 -801 -799
Treasury Stock		 0.00 -0.40 -4.97 -14 -34 -46 -46 -46
Accumulated Other Comprehensive Income / (Loss)		 - - - - - 0.00 -0.05 -0.38

Quarterly Balance Sheets for Phreesia

This table presents Phreesia's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025 4/30/2026 7/31/2026
Total Assets		 354 340 375 372 362 376 400 409 423 666 647
Total Current Assets		 240 219 199 191 181 190 215 223 241 267 254
Restricted Cash		 - - - - - - - - - 75 73
Accounts Receivable		 53 54 57 66 61 71 75 77 88 90 89
Prepaid Expenses		 10 12 14 14 12 11 16 18 20 16 19
Other Current Assets		 27 26 25 31 26 25 33 29 26 87 72
Plant, Property, & Equipment, net		 0.00 0.00 20 22 21 26 23 23 21 0.00 0.00
Total Noncurrent Assets		 114 121 156 159 160 160 161 163 161 399 393
Noncurrent Note & Lease Receivables		 - - - - - - - - - 66 66
Goodwill		 34 41 75 76 76 76 76 76 76 170 171
Intangible Assets		 49 54 77 79 80 80 81 80 80 132 75
Noncurrent Deferred & Refundable Income Taxes		 0.00 0.00 0.00 - - - - 1.64 1.64 1.59 0.99
Other Noncurrent Operating Assets		 31 26 3.28 4.23 4.86 3.98 4.85 5.45 4.35 30 80
Total Liabilities & Shareholders' Equity		 354 340 375 372 362 376 400 409 423 666 647
Total Liabilities		 90 93 110 119 111 121 118 111 103 307 275
Total Current Liabilities		 83 85 98 108 102 109 111 105 99 152 144
Short-Term Debt		 6.98 7.11 6.75 7.75 7.16 8.87 8.35 7.10 6.20 5.30 5.28
Accounts Payable		 7.60 7.95 11 6.68 6.98 16 3.20 6.53 6.22 12 12
Accrued Expenses		 23 28 28 33 33 29 34 35 31 31 36
Current Deferred Revenue		 18 16 22 24 21 22 31 27 30 40 33
Other Current Liabilities		 27 26 30 37 34 33 34 30 26 65 58
Total Noncurrent Liabilities		 7.26 8.55 12 11 8.90 12 7.49 5.51 4.36 155 131
Long-Term Debt		 6.69 8.06 6.85 8.69 7.30 10 6.16 4.58 3.35 85 61
Noncurrent Deferred Revenue		 0.18 0.10 0.10 0.08 0.06 0.20 0.11 0.08 0.15 3.22 4.69
Noncurrent Deferred & Payable Income Tax Liabilities		 0.14 0.18 0.22 0.33 0.39 0.45 0.57 0.63 0.68 4.62 4.59
Other Noncurrent Operating Liabilities		 0.26 0.22 4.46 1.96 1.15 0.97 0.65 0.22 0.17 62 61
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 264 247 265 253 251 255 282 298 320 359 372
Total Preferred & Common Equity		 264 247 265 253 251 255 282 298 320 359 372
Preferred Stock		 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 264 247 265 253 251 255 282 298 320 359 372
Common Stock		 948 972 1,022 1,061 1,078 1,095 1,133 1,148 1,167 1,203 1,213
Retained Earnings		 -644 -680 -712 -763 -781 -795 -805 -805 -800 -796 -794
Treasury Stock		 -41 -44 -46 -46 -46 -46 -46 -46 -46 -47 -47
Accumulated Other Comprehensive Income / (Loss)		 - - - 0.00 -0.00 -0.01 0.38 0.11 -0.36 -0.57 -0.62

Annual Metrics And Ratios for Phreesia

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding		 - - - - - - - - 60,287,003.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 60,287,003.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 0.04
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 25.12% 24.92% 19.15% 43.42% 31.74% 26.84% 17.83% 14.48%
EBITDA Growth		 0.00% 194.53% -232.71% -123.89% -1,166.93% -60.50% 29.34% 75.18% 219.60%
EBIT Growth		 0.00% 20.55% -69.81% -30.78% -355.38% -51.18% 22.80% 58.85% 93.48%
NOPAT Growth		 0.00% 34.76% -61.13% -67.81% -355.05% -51.14% 22.70% 57.43% 88.62%
Net Income Growth		 0.00% 17.21% -34.73% -34.49% -332.95% -49.07% 22.29% 57.24% 103.94%
EPS Growth		 0.00% 1.13% 81.66% 84.67% -243.48% -41.77% 25.30% 59.36% 103.92%
Operating Cash Flow Growth		 0.00% 80.88% 138.78% 249.88% -2,685.12% -20.63% 64.07% 200.01% 143.40%
Free Cash Flow Firm Growth		 0.00% 0.00% 39.63% -93.40% -271.26% 11.72% -20.63% 59.14% -176.03%
Invested Capital Growth		 0.00% 0.00% 34.86% 57.73% 108.94% 1.99% 47.34% 12.20% 84.71%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 6.44% 8.23% 7.08% 5.45% 3.62% 3.75%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -78.48% -63.51% 4.92% 9.77% 46.28% 27.21%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -13.72% -49.12% 3.69% 7.01% 30.03% 23.29%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -16.36% -48.85% 3.71% 6.98% 27.44% 23.71%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% -19.37% -48.06% 4.57% 5.11% 29.30% 142.87%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 6.15% 6.34% 30.14% 140.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 119.45% 3,221.84% -128.79% 19.68% 28.37% 148.19% 28.34%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -84.09% 30.48% 3.58% 15.24% -356.02%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 24.91% 73.54% -0.81% 0.32% 2.48% 62.62%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 62.71% 62.96% 64.16% 64.77% 61.83% 61.10% 65.19% 67.86% 85.15%
EBITDA Margin		 -3.28% 2.48% -2.63% -4.94% -43.66% -53.19% -29.63% -6.24% 6.52%
Operating Margin		 -18.23% -9.50% -12.26% -17.27% -54.78% -62.85% -38.30% -13.84% -1.38%
EBIT Margin		 -18.22% -11.57% -15.73% -17.27% -54.82% -62.91% -38.29% -13.37% -0.76%
Profit (Net Income) Margin		 -22.79% -15.08% -16.26% -18.36% -55.41% -62.71% -38.42% -13.94% 0.48%
Tax Burden Percent		 100.00% 100.00% 91.94% 100.18% 100.15% 100.28% 101.14% 104.87% -25.79%
Interest Burden Percent		 125.04% 130.31% 112.46% 106.13% 100.93% 99.40% 99.20% 99.41% 244.33%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -50.62% -34.73% -39.38% -94.77% -104.85% -64.90% -21.85% -1.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -105.37% 18.96% -32.57% -80.44% -82.45% -31.12% 2.93% -34.86%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 722.43% -6.95% 24.43% 60.05% 54.88% 14.13% -0.82% 2.42%
Return on Equity (ROE)		 0.00% 671.81% -41.68% -14.95% -34.72% -49.96% -50.77% -22.67% 0.77%
Cash Return on Invested Capital (CROIC)		 0.00% -250.62% -64.42% -84.18% -165.29% -106.82% -103.18% -33.35% -61.16%
Operating Return on Assets (OROA)		 0.00% -19.50% -18.01% -10.58% -28.47% -40.88% -36.86% -14.80% -0.70%
Return on Assets (ROA)		 0.00% -25.42% -18.62% -11.24% -28.78% -40.75% -36.98% -15.43% 0.44%
Return on Common Equity (ROCE)		 0.00% 31,608.97% 46.70% -14.95% -34.72% -49.96% -50.77% -22.67% 0.77%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.14% -19.92% -10.37% -28.32% -61.20% -54.44% -22.10% 0.00%
Net Operating Profit after Tax (NOPAT)		 -10 -6.65 -11 -18 -82 -124 -96 -41 -4.63
NOPAT Margin		 -12.76% -6.65% -8.58% -12.09% -38.35% -44.00% -26.81% -9.69% -0.96%
Net Nonoperating Expense Percent (NNEP)		 0.00% 54.75% -53.68% -6.81% -14.33% -22.40% -33.78% -24.79% 33.20%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -41.79% -36.34% -14.47% -1.06%
Cost of Revenue to Revenue		 37.29% 37.04% 35.84% 35.23% 38.17% 38.90% 34.81% 32.14% 14.85%
SG&A Expenses to Revenue		 23.60% 20.10% 24.41% 27.21% 32.21% 28.62% 22.43% 18.25% 16.63%
R&D to Revenue		 14.25% 14.36% 14.92% 15.22% 24.51% 32.48% 31.53% 27.96% 25.28%
Operating Expenses to Revenue		 80.94% 72.47% 76.42% 82.03% 116.62% 123.95% 103.50% 81.70% 86.53%
Earnings before Interest and Taxes (EBIT)		 -15 -12 -20 -26 -117 -177 -136 -56 -3.66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.62 2.47 -3.28 -7.35 -93 -149 -106 -26 31
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 10.92 10.95 3.83 6.87 5.64 6.25 2.40
Price to Tangible Book Value (P/TBV)		 0.00 0.00 12.13 11.92 4.52 9.53 14.49 15.31 24.45
Price to Revenue (P/Rev)		 2.09 1.67 8.91 19.39 7.50 7.04 3.98 3.94 1.68
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 351.11
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.28%
Enterprise Value to Invested Capital (EV/IC)		 0.00 15.40 29.54 47.90 11.12 15.20 7.65 8.06 2.30
Enterprise Value to Revenue (EV/Rev)		 0.00 4.05 8.38 18.00 6.09 6.44 3.77 3.78 1.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 163.53 0.00 0.00 0.00 0.00 0.00 0.00 26.67
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 1,266.33 925.93 0.00 0.00 0.00 48.99 10.61
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 -7.20 0.23 0.04 0.03 0.03 0.05 0.06 0.30
Long-Term Debt to Equity		 0.00 -6.76 0.21 0.02 0.02 0.01 0.02 0.03 0.27
Financial Leverage		 0.00 -6.86 -0.37 -0.75 -0.75 -0.67 -0.45 -0.28 -0.07
Leverage Ratio		 0.00 -13.22 2.24 1.33 1.21 1.23 1.37 1.47 1.75
Compound Leverage Factor		 0.00 -17.22 2.52 1.41 1.22 1.22 1.36 1.46 4.27
Debt to Total Capital		 0.00% 116.13% 18.98% 4.13% 3.08% 2.67% 4.36% 5.76% 22.89%
Short-Term Debt to Total Capital		 0.00% 7.07% 1.85% 1.77% 1.35% 1.75% 2.30% 2.86% 1.82%
Long-Term Debt to Total Capital		 0.00% 109.06% 17.13% 2.36% 1.72% 0.92% 2.05% 2.90% 21.07%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 742.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -758.87% 81.02% 95.87% 96.92% 97.33% 95.64% 94.24% 77.11%
Debt to EBITDA		 0.00 13.06 -7.27 -1.54 -0.14 -0.05 -0.11 -0.62 3.19
Net Debt to EBITDA		 0.00 12.43 20.25 28.23 3.23 1.13 0.72 2.60 0.84
Long-Term Debt to EBITDA		 0.00 12.26 -6.56 -0.88 -0.08 -0.02 -0.05 -0.31 2.94
Debt to NOPAT		 0.00 -4.86 -2.23 -0.63 -0.16 -0.06 -0.12 -0.40 -21.62
Net Debt to NOPAT		 0.00 -4.63 6.21 11.54 3.68 1.37 0.80 1.67 -5.67
Long-Term Debt to NOPAT		 0.00 -4.56 -2.01 -0.36 -0.09 -0.02 -0.06 -0.20 -19.90
Altman Z-Score		 0.00 -2.26 10.33 26.96 11.63 11.91 4.37 6.02 0.68
Noncontrolling Interest Sharing Ratio		 0.00% -4,605.04% 212.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 1.19 3.72 4.95 5.65 3.32 1.78 1.78 1.53
Quick Ratio		 0.00 0.63 3.18 4.51 5.17 2.89 1.38 1.38 0.53
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -33 -20 -38 -143 -126 -152 -62 -171
Operating Cash Flow to CapEx		 -93.12% -21.66% 6.70% 15.56% -242.53% -343.94% -129.01% 134.42% 323.05%
Free Cash Flow to Firm to Interest Expense		 0.00 -9.39 -8.12 -24.42 -131.57 0.00 -135.86 0.00 -22.98
Operating Cash Flow to Interest Expense		 -3.06 -0.61 0.34 1.84 -68.92 0.00 -28.96 0.00 10.57
Operating Cash Flow Less CapEx to Interest Expense		 -6.34 -3.41 -4.70 -9.97 -97.34 0.00 -51.41 0.00 7.30
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 1.69 1.14 0.61 0.52 0.65 0.96 1.11 0.91
Accounts Receivable Turnover		 0.00 6.21 6.56 5.83 6.15 6.13 6.13 6.06 5.62
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 7.03 8.70 0.00 0.00 0.00 18.47 20.70 0.00
Accounts Payable Turnover		 0.00 9.87 9.16 10.07 17.12 13.70 12.84 19.14 8.35
Days Sales Outstanding (DSO)		 0.00 58.73 55.65 62.64 59.32 59.55 59.55 60.20 64.96
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 37.00 39.86 36.25 21.32 26.65 28.43 19.07 43.73
Cash Conversion Cycle (CCC)		 0.00 21.74 15.79 26.39 38.00 32.90 31.12 41.13 21.24
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 26 35 56 117 119 175 197 363
Invested Capital Turnover		 0.00 7.61 4.05 3.26 2.47 2.38 2.42 2.26 1.72
Increase / (Decrease) in Invested Capital		 0.00 26 9.16 20 61 2.32 56 21 167
Enterprise Value (EV)		 0.00 404 1,046 2,676 1,298 1,809 1,342 1,586 836
Market Capitalization		 167 167 1,112 2,883 1,598 1,977 1,418 1,654 810
Book Value per Share		 $0.00 ($114.35) $2.84 $5.96 $8.14 $5.46 $4.52 $4.56 $5.59
Tangible Book Value per Share		 $0.00 ($119.50) $2.55 $5.48 $6.89 $3.93 $1.76 $1.86 $0.55
Total Capital		 0.00 28 126 275 431 296 263 281 437
Total Debt		 0.00 32 24 11 13 7.90 11 16 100
Total Long-Term Debt		 0.00 30 22 6.47 7.42 2.73 5.40 8.15 92
Net Debt		 0.00 31 -66 -207 -301 -169 -76 -68 26
Capital Expenditures (CapEx)		 12 9.83 12 19 31 26 25 24 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 5.81 8.19 3.36 9.93 12 4.10 13 31
Debt-free Net Working Capital (DFNWC)		 0.00 7.35 99 222 324 189 92 97 105
Net Working Capital (NWC)		 0.00 5.39 96 217 318 183 86 89 97
Net Nonoperating Expense (NNE)		 8.00 8.42 9.58 9.32 36 53 41 18 -6.93
Net Nonoperating Obligations (NNO)		 0.00 31 -66 -207 -301 -169 -76 -68 26
Total Depreciation and Amortization (D&A)		 12 14 16 18 24 27 31 30 35
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 5.82% 6.57% 2.26% 4.66% 4.23% 1.15% 3.12% 6.40%
Debt-free Net Working Capital to Revenue		 0.00% 7.36% 78.94% 149.41% 151.82% 67.13% 25.71% 23.18% 21.76%
Net Working Capital to Revenue		 0.00% 5.39% 77.08% 146.14% 149.09% 65.29% 24.01% 21.26% 20.10%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 37.52M 44.90M 49.89M 52.44M 54.56M 57.59M 59.74M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 37.52M 44.90M 49.89M 52.44M 54.56M 57.59M 61.49M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($4.50) ($0.69) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 20.30M 39.52M 51.95M 53.36M 56.39M 58.77M 60.76M
Normalized Net Operating Profit after Tax (NOPAT)		 -10 -6.65 -11 -18 -82 -124 -96 -41 -4.63
Normalized NOPAT Margin		 -12.76% -6.65% -8.58% -12.09% -38.35% -44.00% -26.81% -9.69% -0.96%
Pre Tax Income Margin		 -22.79% -15.08% -17.69% -18.32% -55.33% -62.53% -37.99% -13.29% -1.86%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -3.99 -3.30 -8.03 -16.32 -107.84 0.00 -122.03 0.00 -0.49
NOPAT to Interest Expense		 -2.80 -1.90 -4.38 -11.42 -75.44 0.00 -85.45 0.00 -0.62
EBIT Less CapEx to Interest Expense		 -7.28 -6.11 -13.07 -28.13 -136.25 0.00 -144.48 0.00 -3.76
NOPAT Less CapEx to Interest Expense		 -6.08 -4.70 -9.42 -23.23 -103.85 0.00 -107.90 0.00 -3.89
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% -73.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -1.29% -104.33% -1.06% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Phreesia

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
DEI Shares Outstanding		 - - - - - - - - 60,287,003.00 60,763,065.00 61,811,889.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 60,287,003.00 60,763,065.00 61,811,889.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 0.02 0.05 0.03
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 24.05% 20.72% 18.97% 16.57% 15.45% 14.54% 14.83% 12.67% 15.85% 12.94% 10.41%
EBITDA Growth		 35.27% 58.97% 67.20% 77.31% 107.62% 132.74% 167.02% 324.71% 419.26% 320.53% 128.60%
EBIT Growth		 25.86% 48.74% 53.10% 56.42% 81.71% 84.84% 93.23% 133.92% 20.59% 328.62% 503.07%
NOPAT Growth		 25.71% 48.76% 53.40% 56.80% 74.26% 83.07% 91.25% 132.16% 27.00% 284.02% 527.07%
Net Income Growth		 19.40% 47.45% 51.01% 54.91% 79.15% 80.15% 103.63% 129.65% 120.27% 175.70% 193.27%
EPS Growth		 23.61% 50.00% 54.41% 56.90% 80.00% 80.00% 103.23% 128.00% 127.27% 171.43% 200.00%
Operating Cash Flow Growth		 80.64% 94.72% 218.54% 191.68% 628.14% 2,159.64% 34.12% 167.36% 107.07% 61.09% 23.55%
Free Cash Flow Firm Growth		 -155.24% -153.12% -46.55% 65.22% 65.32% 75.60% 53.77% -5.63% -538.27% -792.67% -425.27%
Invested Capital Growth		 47.34% 48.73% 36.79% 9.83% 12.20% 8.53% 14.89% 16.41% 84.71% 82.19% 72.83%
Revenue Q/Q Growth		 3.70% 6.54% 0.89% 4.59% 2.70% 5.70% 1.14% 2.63% 5.60% 3.04% -1.13%
EBITDA Q/Q Growth		 13.73% 40.28% 22.06% 43.50% 128.99% 156.47% 59.52% 89.47% -33.01% 107.71% -13.28%
EBIT Q/Q Growth		 8.09% 34.05% 11.02% 19.19% 61.43% 45.34% 60.29% 505.21% -190.28% 257.38% -29.99%
NOPAT Q/Q Growth		 7.70% 34.34% 11.32% 19.62% 45.01% 56.82% 54.15% 395.38% -224.84% 208.85% 6.40%
Net Income Q/Q Growth		 4.05% 35.65% 8.67% 20.04% 55.63% 38.75% 116.71% 553.06% -69.68% 128.80% -35.27%
EPS Q/Q Growth		 5.17% 36.36% 11.43% 19.35% 56.00% 36.36% 114.29% 600.00% -57.14% 66.67% -40.00%
Operating Cash Flow Q/Q Growth		 51.22% 76.58% 1,634.12% -47.70% 181.00% -8.65% -0.10% 4.26% 117.64% -28.93% -23.38%
Free Cash Flow Firm Q/Q Growth		 0.26% 1.72% 18.74% 56.34% 0.54% 30.87% -54.00% 0.24% -500.95% 3.31% 9.38%
Invested Capital Q/Q Growth		 0.32% 8.13% -2.98% 4.36% 2.48% 4.60% 2.71% 5.73% 62.62% 3.17% -2.57%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 66.56% 66.39% 67.87% 67.66% 69.40% 67.17% 67.90% 68.40% 133.34% 86.51% 85.11%
EBITDA Margin		 -22.08% -12.37% -9.56% -5.16% 1.46% 3.54% 5.58% 10.30% 6.53% 13.17% 11.55%
Operating Margin		 -31.13% -19.19% -16.87% -12.96% -6.94% -2.84% -1.29% 3.11% -4.37% 5.15% 5.88%
EBIT Margin		 -31.05% -19.22% -16.95% -13.10% -4.92% -2.54% -1.00% 3.94% -3.37% 5.15% 3.65%
Profit (Net Income) Margin		 -32.26% -19.48% -17.64% -13.49% -5.83% -3.38% 0.56% 3.55% 1.02% 2.26% 1.48%
Tax Burden Percent		 100.71% 102.65% 104.34% 103.17% 118.86% 123.12% -116.16% 83.34% -12.54% 62.74% 59.22%
Interest Burden Percent		 103.17% 98.77% 99.73% 99.81% 99.65% 107.80% 48.08% 108.01% 240.97% 70.05% 68.62%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.66% 0.00% 37.26% 40.78%
Return on Invested Capital (ROIC)		 -52.75% -31.65% -28.91% -20.04% -10.96% -4.36% -2.05% 5.77% -5.25% 5.52% 6.13%
ROIC Less NNEP Spread (ROIC-NNEP)		 -44.63% -25.49% -22.28% -13.85% -9.49% -2.05% -4.27% 4.32% -30.08% 9.72% 11.69%
Return on Net Nonoperating Assets (RNNOA)		 20.26% 9.83% 8.04% 4.07% 2.65% 0.53% 1.20% -1.20% 2.09% -0.92% -1.62%
Return on Equity (ROE)		 -32.48% -21.81% -20.87% -15.98% -8.31% -3.83% -0.85% 4.57% -3.17% 4.60% 4.50%
Cash Return on Invested Capital (CROIC)		 -103.18% -91.27% -74.27% -39.92% -33.35% -23.04% -23.15% -18.08% -61.16% -57.43% -36.95%
Operating Return on Assets (OROA)		 -29.88% -19.78% -18.81% -14.14% -5.44% -2.86% -1.17% 4.57% -3.08% 4.79% 3.51%
Return on Assets (ROA)		 -31.05% -20.06% -19.58% -14.56% -6.45% -3.80% 0.65% 4.11% 0.93% 2.10% 1.43%
Return on Common Equity (ROCE)		 -32.48% -21.81% -20.87% -15.98% -8.31% -3.83% -0.85% 4.57% -3.17% 4.60% 4.50%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -47.11% -39.92% -32.52% 0.00% -15.14% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -14 -12 -9.69 -5.33 -2.30 -1.05 3.12 -3.89 4.23 4.51
NOPAT Margin		 -21.79% -13.43% -11.81% -9.07% -4.86% -1.98% -0.90% 2.59% -3.06% 3.23% 3.48%
Net Nonoperating Expense Percent (NNEP)		 -8.12% -6.15% -6.62% -6.19% -1.47% -2.31% 2.22% 1.45% 24.83% -4.20% -5.56%
Return On Investment Capital (ROIC_SIMPLE)		 -7.88% - - - -1.90% -0.78% -0.34% 0.94% -0.89% 0.94% 1.03%
Cost of Revenue to Revenue		 33.44% 33.61% 32.13% 32.34% 30.60% 32.83% 32.10% 31.60% -33.34% 13.49% 14.89%
SG&A Expenses to Revenue		 19.81% 18.82% 19.09% 18.38% 16.79% 14.15% 16.24% 14.53% 21.22% 14.02% 12.75%
R&D to Revenue		 31.43% 28.53% 28.93% 27.45% 27.01% 27.45% 24.97% 24.48% 24.34% 21.64% 21.30%
Operating Expenses to Revenue		 97.69% 85.58% 84.73% 80.62% 76.34% 70.00% 69.18% 65.29% 137.72% 81.36% 79.24%
Earnings before Interest and Taxes (EBIT)		 -29 -19 -17 -14 -5.40 -2.95 -1.17 4.75 -4.28 6.74 4.72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -21 -13 -9.76 -5.52 1.60 4.10 6.54 12 8.30 17 15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.64 4.63 5.70 4.15 6.25 5.20 5.38 4.23 2.40 1.56 1.78
Price to Tangible Book Value (P/TBV)		 14.49 11.95 14.94 10.74 15.31 11.69 11.31 8.23 24.45 9.68 5.27
Price to Revenue (P/Rev)		 3.98 3.13 3.67 2.61 3.94 3.38 3.57 2.93 1.68 1.13 1.31
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 351.11 60.94 63.49
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.28% 1.64% 1.58%
Enterprise Value to Invested Capital (EV/IC)		 7.65 5.83 7.42 5.18 8.06 6.76 7.18 5.64 2.30 1.53 1.80
Enterprise Value to Revenue (EV/Rev)		 3.77 2.96 3.50 2.45 3.78 3.20 3.38 2.72 1.74 1.16 1.29
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 225.64 51.13 26.67 12.94 12.42
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 95.41 55.08
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 240.12 13.86
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 1,433.55 76.19 48.99 29.00 29.34 20.51 10.61 6.55 7.19
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.05 0.07 0.06 0.08 0.06 0.05 0.04 0.03 0.30 0.25 0.18
Long-Term Debt to Equity		 0.02 0.03 0.03 0.04 0.03 0.02 0.02 0.01 0.27 0.24 0.16
Financial Leverage		 -0.45 -0.39 -0.36 -0.29 -0.28 -0.26 -0.28 -0.28 -0.07 -0.09 -0.14
Leverage Ratio		 1.37 1.41 1.41 1.45 1.47 1.44 1.40 1.39 1.75 1.66 1.58
Compound Leverage Factor		 1.42 1.39 1.41 1.44 1.46 1.56 0.67 1.50 4.21 1.17 1.08
Debt to Total Capital		 4.36% 6.11% 5.44% 7.00% 5.76% 4.89% 3.77% 2.90% 22.89% 20.15% 15.16%
Short-Term Debt to Total Capital		 2.30% 2.88% 2.69% 3.24% 2.86% 2.81% 2.29% 1.88% 1.82% 1.18% 1.20%
Long-Term Debt to Total Capital		 2.05% 3.23% 2.75% 3.76% 2.90% 2.08% 1.48% 1.02% 21.07% 18.97% 13.96%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 95.64% 93.89% 94.56% 93.00% 94.24% 95.11% 96.23% 97.10% 77.11% 79.85% 84.84%
Debt to EBITDA		 -0.11 -0.19 -0.21 -0.39 -0.62 -1.51 1.74 0.39 3.19 2.04 1.26
Net Debt to EBITDA		 0.72 0.72 1.00 1.28 2.60 7.97 -12.87 -3.93 0.84 0.36 -0.12
Long-Term Debt to EBITDA		 -0.05 -0.10 -0.11 -0.21 -0.31 -0.64 0.68 0.14 2.94 1.92 1.16
Debt to NOPAT		 -0.12 -0.20 -0.21 -0.34 -0.40 -0.49 -0.64 -1.57 -21.62 37.80 1.40
Net Debt to NOPAT		 0.80 0.76 0.98 1.12 1.67 2.60 4.71 15.96 -5.67 6.63 -0.14
Long-Term Debt to NOPAT		 -0.06 -0.11 -0.11 -0.18 -0.20 -0.21 -0.25 -0.55 -19.90 35.59 1.29
Altman Z-Score		 5.32 4.11 5.91 3.48 6.45 6.00 7.38 6.78 0.68 0.41 0.74
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.78 1.76 1.77 1.74 1.78 1.95 2.12 2.44 1.53 1.76 1.76
Quick Ratio		 1.38 1.35 1.40 1.40 1.38 1.50 1.67 1.97 0.53 0.59 0.62
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -77 -76 -62 -27 -27 -18 -28 -28 -171 -165 -149
Operating Cash Flow to CapEx		 -39.14% -13.24% 149.41% 138.33% 230.32% 200.89% 285.18% 232.03% 655.29% 316.85% 406.93%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -71.21 -86.44
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.33 10.60
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.07 8.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.96 1.03 1.11 1.08 1.11 1.13 1.17 1.16 0.91 0.93 0.96
Accounts Receivable Turnover		 6.13 6.27 6.77 6.29 6.06 6.15 6.51 5.80 5.62 6.02 6.11
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 18.47 0.00 0.00 17.66 20.70 19.06 20.57 19.68 0.00 0.00 0.00
Accounts Payable Turnover		 12.84 17.78 17.36 9.95 19.14 28.11 21.30 13.34 8.35 9.59 7.92
Days Sales Outstanding (DSO)		 59.55 58.21 53.91 58.04 60.20 59.37 56.05 62.91 64.96 60.65 59.75
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 28.43 20.52 21.02 36.70 19.07 12.98 17.14 27.37 43.73 38.06 46.11
Cash Conversion Cycle (CCC)		 31.12 37.69 32.88 21.34 41.13 46.38 38.92 35.54 21.24 22.60 13.64
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 175 190 184 192 197 206 211 224 363 375 365
Invested Capital Turnover		 2.42 2.36 2.45 2.21 2.26 2.20 2.27 2.23 1.72 1.71 1.76
Increase / (Decrease) in Invested Capital		 56 62 49 17 21 16 27 32 167 169 154
Enterprise Value (EV)		 1,342 1,106 1,365 994 1,586 1,391 1,518 1,260 836 576 657
Market Capitalization		 1,418 1,169 1,432 1,057 1,654 1,467 1,604 1,356 810 560 663
Book Value per Share		 $4.52 $4.48 $4.38 $4.41 $4.56 $4.80 $5.01 $5.35 $5.59 $5.91 $6.02
Tangible Book Value per Share		 $1.76 $1.74 $1.67 $1.70 $1.86 $2.14 $2.38 $2.75 $0.55 $0.95 $2.04
Total Capital		 263 269 266 274 281 297 310 330 437 450 438
Total Debt		 11 16 14 19 16 15 12 9.55 100 91 66
Total Long-Term Debt		 5.40 8.69 7.30 10 8.15 6.16 4.58 3.35 92 85 61
Net Debt		 -76 -63 -67 -63 -68 -76 -87 -97 26 16 -6.50
Capital Expenditures (CapEx)		 7.86 5.45 7.40 4.18 7.06 7.39 5.20 6.67 5.14 7.55 4.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.10 11 4.29 7.50 13 22 26 42 31 46 42
Debt-free Net Working Capital (DFNWC)		 92 90 86 89 97 113 125 148 105 120 115
Net Working Capital (NWC)		 86 83 79 80 89 105 118 142 97 115 110
Net Nonoperating Expense (NNE)		 9.94 6.13 5.96 4.71 1.06 1.61 -1.71 -1.16 -5.18 1.27 2.59
Net Nonoperating Obligations (NNO)		 -76 -63 -67 -63 -68 -76 -87 -97 26 16 -6.50
Total Depreciation and Amortization (D&A)		 8.52 6.93 7.55 8.47 6.99 7.05 7.71 7.65 13 11 10
Debt-free, Cash-free Net Working Capital to Revenue		 1.15% 2.90% 1.10% 1.85% 3.12% 5.10% 5.86% 9.06% 6.40% 9.23% 8.27%
Debt-free Net Working Capital to Revenue		 25.71% 24.18% 22.08% 22.03% 23.18% 26.01% 27.71% 32.02% 21.76% 24.31% 22.64%
Net Working Capital to Revenue		 24.01% 22.11% 20.24% 19.84% 21.26% 24.09% 26.13% 30.68% 20.10% 23.24% 21.60%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Adjusted Weighted Average Basic Shares Outstanding		 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 59.59M 60.01M 59.74M 60.94M 61.88M
Adjusted Diluted Earnings per Share		 ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Adjusted Weighted Average Diluted Shares Outstanding		 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 61.69M 61.56M 61.49M 62.04M 62.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 56.39M 57.40M 57.77M 58.12M 58.77M 59.50M 59.91M 60.29M 60.76M 61.81M 62.07M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -14 -12 -9.69 -5.33 -2.30 -1.05 3.12 -3.89 4.23 4.51
Normalized NOPAT Margin		 -21.79% -13.43% -11.81% -9.07% -4.86% -1.98% -0.90% 2.59% -3.06% 3.23% 3.48%
Pre Tax Income Margin		 -32.03% -18.98% -16.90% -13.07% -4.90% -2.74% -0.48% 4.26% -8.12% 3.61% 2.50%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.91 2.73
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.83 2.61
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.35 0.12
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.43 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Phreesia’s financial profile has improved materially over the past several years. Revenue increased from $58.0 million in Q4 2022 to $129.5 million in Q2 2027, while the company has progressed from substantial operating and net losses to positive earnings in each of the latest reported quarters. However, the latest quarter also shows softer sequential revenue, lower cash balances and a much higher debt load than a year earlier.

  • Revenue continues to expand. Q2 2027 revenue was $129.5 million, up 10.4% from $117.3 million in Q2 2026 and more than double the $63.4 million reported in Q1 2023. Revenue declined modestly from $130.9 million in Q1 2027, indicating some near-term slowing but continued long-term growth.
  • Gross profitability remains strong. Gross profit was $110.2 million in Q2 2027, representing an approximately 85.1% gross margin. The margin was broadly consistent with Q1 2027 and Q2 2026, suggesting that revenue growth has not materially weakened Phreesia’s core economics.
  • Operating profitability has remained positive in recent quarters. Q2 operating income was $7.6 million, compared with $6.7 million in Q1 2027 and a $1.5 million operating loss in Q2 2026. This reflects progress in absorbing selling, marketing, research and development costs as the business scales.
  • Phreesia generated positive operating cash flow. Operating cash flow was $18.3 million in Q2 2027 and $23.9 million in Q1 2027, compared with $14.8 million in Q2 2026. The company has produced positive operating cash flow in every quarter provided from Q2 2025 through Q2 2027, despite earlier periods of operating cash burn.
  • The company has reached positive net income. Q2 2027 net income was $1.9 million, following $3.0 million in Q1 2027 and $1.3 million in Q4 2026. This compares with a $0.7 million profit in Q2 2026 and a $19.7 million loss in Q1 2026, indicating a significant improvement in bottom-line performance.
  • Debt was reduced sequentially. Total short- and long-term debt declined to approximately $66.4 million at the end of Q2 2027 from $90.6 million in Q1 2027, reflecting $41.3 million of debt repayments during the quarter. Lower debt should reduce refinancing risk and future interest costs if the trend continues.
  • Shareholders’ equity increased. Total equity rose to $371.9 million in Q2 2027 from $359.1 million in Q1 and $298.0 million in Q2 2026. The increase reflects positive earnings and additional common stock issuance, although investors should also monitor the resulting share dilution.
  • Liquidity remains substantial but is changing in composition. Total current assets were $253.5 million, compared with $267.3 million in Q1 2027. Restricted cash accounted for $72.9 million of the latest balance, meaning not all reported current assets may be freely available for general corporate purposes.
  • Investing cash flow was unusually positive. Phreesia reported $22.2 million of investing cash inflow in Q2 2027 despite $4.5 million of capital expenditures, primarily because of $26.7 million in other investing activities. Investors may want to determine whether this inflow is recurring or related to one-time asset movements.
  • Intangible assets and goodwill represent a meaningful portion of the asset base. Goodwill and intangible assets totaled approximately $246.0 million at the end of Q2 2027, or roughly 38% of total assets. This could increase the company’s exposure to impairment charges if expected growth or acquisition returns weaken.
  • Cash declined during the latest quarter. Net cash and equivalents decreased by $1.8 million in Q2 2027, as $42.3 million of financing outflows more than offset operating and investing inflows. Continued debt repayments could pressure cash balances even while operating cash flow remains positive.
  • Debt remains considerably higher than a year ago. Q2 2027 total debt of approximately $66.4 million was well above the roughly $11.7 million reported in Q2 2026. Although debt declined sequentially, the year-over-year increase raises interest-rate and refinancing risks.
  • Sequential revenue growth has stalled. Q2 revenue declined approximately 1.1% from Q1 2027. A sustained decline would make it more difficult for Phreesia to leverage its cost base and maintain recent improvements in operating margins.
  • Operating expenses remain high relative to revenue. Total operating expenses were $102.6 million in Q2 2027, equal to about 79% of revenue. Marketing, research and development, other operating expenses and amortization continue to consume a large portion of gross profit, leaving the company’s operating margin at only about 5.9%.
  • Share dilution is an ongoing consideration. Basic weighted-average shares increased to approximately 61.9 million in Q2 2027 from 59.6 million in Q4 2026 and 59.2 million in Q4 2025. Additional equity issuance can support liquidity but reduces each existing shareholder’s ownership percentage and may limit per-share earnings growth.
  • Accumulated retained earnings remain deeply negative. Retained earnings stood at negative $794.3 million in Q2 2027. Although current earnings are positive, Phreesia will need sustained profitability to rebuild this deficit and demonstrate durable earnings power.
10/12/26 08:52 PM ETAI Generated. May Contain Errors.

Phreesia Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Phreesia's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Phreesia's net income appears to be on a downward trend, with a most recent value of $2.31 million in 2026, compared with -$18.19 million in 2018. The previous period was -$58.53 million in 2025. See Phreesia's forecast for analyst expectations on what's next for the company.

Phreesia's total operating income in 2026 was -$6.61 million, based on the following breakdown:
  • Total Gross Profit: $409.23 million
  • Total Operating Expenses: $415.84 million

Over the last 8 years, Phreesia's total revenue changed from $79.83 million in 2018 to $480.59 million in 2026, a change of 502.0%.

Phreesia had total debt of $100.09 million at the end of 2026, a 518.1% increase from 2025, and none in 2018.

Over the last 8 years, Phreesia's book value per share changed from 0.00 in 2018 to 5.59 in 2026, a change of 559.3%.


Related Companies

Financial statements for NYSE:PHR last updated on 9/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Palantir and Wall Street are in on it…
Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...
Monument Traders Alliance | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
A new income category is drawing serious money - here's why
Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...
Investors Alley | Sponsoredtc pixel
My biggest prediction yet?!
James Altucher called Facebook's rise past 100 billion dollars in 2007 and Apple's run to a trillion years lat...
Paradigm Press | Sponsoredtc pixel
The AI Stock to Keep an Eye on Before Election Day (See Why)
In 2019, Charles Mizrahi named Marvell Technology his top AI pick. It's since climbed 1300 percent. Now he'...
Prosperity Research | Sponsoredtc pixel
Trump To Relaunch USD?
President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...
Porter & Company | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel